Sales decline 2.41% to Rs 302.63 crore
Dr Reddys Laboratories has allotted 2715 equity shares under ESOS on 27 October 2022. Powered by Capital Market – Live News
Sales rise 1678.72% to Rs 8.36 crore
The company is considering a buyback through the tender offer route.
Sales rise 27.10% to Rs 879.29 crore
Sales rise 18.81% to Rs 39.61 crore
Metal stocks were trading in the negative zone, with the S&P BSE Metal index falling 337.74 points or 1.75% at 18927.08 at 13:45 IST.
Dr Reddys Laboratories has granted 3820 Indian stock options and 14,002 American Depository Receipts stock options under Dr. Reddys Stock Option Scheme, 2018 and Dr. Reddys Employees ADR Stock Option Scheme, 2007, respectively. Powered by Capital Market – Live News
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
